Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (4) , 537-545
- https://doi.org/10.1097/00004872-199917040-00012
Abstract
We have demonstrated that accumulated macrophages in human coronary arteries strongly express angiotensin converting enzyme in accordance with the development of atheromatous plaques. However, there are few reports on the regulation of the renin-angiotensin system in macrophages and in monocytes as their source. To examine whether the renin-angiotensin system is upregulated during the differentiation of monocytes to macrophages, and whether it is further regulated by angiotensin II and cytokines. We used a human leukemia cell line, THP-1, for monocytes. Differentiated THP-1, induced by adding phorbol 12-myristate 13-acetate for 24 h, were used as macrophages. Expression of messenger RNA of the renin-angiotensin system components was measured by quantitative reverse-transcriptase polymerase chain reaction. Angiotensin converting enzyme activity and subtype-specific angiotensin-binding sites of cultured cells, and angiotensin II production in the culture medium were measured. Macrophages expressed all components of the renin-angiotensin system except chymase. Cellular angiotensin converting enzyme activity and angiotensin II in the medium were increased 3.2and 4.5-fold during differentiation, respectively. Expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors was increased 6.2and 6.4-fold during differentiation, and was sustained for 7 days. Incubation with angiotensin II for 24 h caused downregulation of both AT1 and AT2 receptor messenger RNA, but the expression levels were still more than threefold higher compared with monocytes. The density of binding sites of AT1 and AT2 receptors in macrophages was 0.26 ± 0.02 and 0.15 ± 0.01 fmol/106 cells, respectively. The renin-angiotensin system is markedly activated during monocyte/macrophage differentiation, and may participate in the development of atherosclerosis.Keywords
This publication has 41 references indexed in Scilit:
- Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans.Circulation, 1997
- Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humansJournal Of Hypertension, 1997
- Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery DiseaseCirculation, 1996
- Effect of angiotensin II receptor blocker on angiotensin II stimulated dna synthesis of cultured human aortic smooth muscle cellsLife Sciences, 1995
- Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.Journal of Clinical Investigation, 1994
- Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin IIAtherosclerosis, 1994
- Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.Journal of Clinical Investigation, 1994
- Vascular injury induces angiotensinogen gene expression in the media and neointima.Circulation, 1993
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.Circulation Research, 1988